-
Q2 2025: A recap of the top headlines and interviews
03 Jul 2025 18:40 GMT
… infants. In the CLEVER trial, clesrovimab reduced medically attended lower respiratory infections … in both trials. The treatment demonstrated superiority over once-daily oral Truvada (F … 17, 2025, the FDA accepted the new drug application for epinephrine …
-
Optum Rx Eliminates Reauthorization on an Additional 60 Drugs
30 Jun 2025 21:20 GMT
… drugs that treat chronic conditions. The newly added medications include treatments … capsules, Eprontia, Elepsia XR
• Antidepressants: Aplenzin, Forfivo XL, Bupropion XL … , Fenoglide, Fibricor
• HIV: Descovy, Truvada, Vocabria, Selzentry, Sunlenca
• Dry Eye …
-
The FDA Approved a Twice-Yearly HIV Drug, Will it Be Accessible?
30 Jun 2025 03:32 GMT
… Oral PrEP
In clinical trials, the Yeztugo injections were … daily oral PrEP medication, Truvada. The first trial resulted in zero … been significant advances in treatment, which have resulted in … Therefore, having coverage for this drug will be vital.
However, …
-
Gilead Eyes HIV Market Domination With Twice-Yearly Yeztugo as GSK Trails
02 Jul 2025 04:07 GMT
… of patients take Truvada, Gilead’s old PrEP drug, or generic … pools of patients the big biotech will target as it seeks … Day said. The new drug could improve treatment compliance, which O’Day … around 50% for daily pills.
The HIV doctor expects Yeztugo to be …
-
Twice-yearly injection could transform HIV prevention efforts
03 Jul 2025 13:47 GMT
… clinicals trials leading up to FDA approval of the medication.
This … once-daily Truvada.
The PURPOSE 2 clinical trial was designed … just leaving prison, receiving treatment for intravenous substance abuse, … protective properties of the drug are key, as people …
-
Analysis shows Yeztugo approval a ‘momentous step’ for HIV prevention
02 Jul 2025 17:17 GMT
… .
The drug will compete with Gilead’s own oral PrEP therapies – Truvada … HIV treatment space, as the FDA paused several clinical trials evaluating two drug candidates … now open for the prestigious Pharmaceutical Technology Excellence Awards - one …
-
US approves Gilead's twice-yearly injection to prevent HIV
01 Jul 2025 19:32 GMT
… tempered by the drug';s cost. [AFP]
Drugs to prevent … the daily oral pill Truvada.
In the second trial, involving over 2 … rate, again surpassing Truvada.
Reported side effects included … both trials were published in The New England Journal of Medicine, …
-
Twice Yearly HIV Prevention Shot, Yeztugo, May Face Access Hurdles
01 Jul 2025 16:37 GMT
… for Gilead's lenacapavir drug trial. (AP Photo/ … cabotegravir) and once-daily pills which include Truvada (emtricitabine/tenofovir).
… by the FDA in 2022 as a treatment for HIV … the commercial and public (Medicaid and Medicare) sectors to offer …
-
SCOTUS ruling paves smooth launch path for Gilead's long-acting PrEP med Yeztugo, analyst says
01 Jul 2025 16:49 GMT
… oral PrEP drugs Truvada and Descovy, but the company just won FDA approval … .
The company’s Advancing Access medication assistance program is set up … , driven by Descovy and HIV treatment Biktarvy.
Outside of the implications …
-
HIV prevention advances, but stigma persists
30 Jun 2025 17:06 GMT
… antiretroviral drugs used to treat and prevent HIV. Truvada, one … of the most widely used prevention medications, must … around taking an HIV pill to prevent HIV,” she … inform patients about prevention and treatment options. (RHCJC News)
Dr …